Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Self-administration may be permitted within a clinical trial if your trial team has provided hands-on training and the protocol allows it
Clinical studies have demonstrated that both Ozempic and Wegovy are effective for obesity management and weight loss, with the active ingredient semaglutide showing clinically effective results at 3 and 6 months in individuals who are overweight
Mounjaro (tirzepatide): Approved for type 2 diabetes
Ozempic also produces beneficial reductions in blood pressure of approximately 35 mmHg, which reduces strain on the heart and vascular system
Semaglutide lowers glucose levels , which is helpful for people with type 2 diabetes, but it can also raise the risk of hypoglycemia if combined with other medications like insulin or sulfonylureas
US$ 25.44
US$ 26.59
US$ 24.95
US$ 22.87
US$ 28.98
